FORMA THERAPEUTICS ANNOUNCES ADVANCEMENT OF COLLABORATION WITH BOEHRINGER INGELHEIM FOR MODULATING PROTEIN-PROTEIN INTERACTIONS IN THE TREATMENT OF CANCER